selank mastery course
Unit 4 of 11

neurotrophic effects

BDNF, gene expression, and cognitive enhancement

beyond anxiolysis -- building better circuits

selank upregulates BDNF and NGF expression in the hippocampus and cortex, promoting neuroplasticity. this may explain the nootropic effects reported alongside anxiety reduction. this unit examines the neurotrophic evidence.

neurotrophic effects (promoting nerve cell growth and survival) are distinct from selank's anxiolytic effects. they may explain the nootropic (cognitive enhancement) benefits reported alongside anxiety reduction.

neurotrophic snapshot

key findings from animal and in-vitro studies.

BDNF
brain-derived neurotrophic factor upregulated in hippocampus
NGF
nerve growth factor expression increased in cortex
~400 genes
expression altered in rat hippocampus after selank administration
neuroplasticity
enhanced synaptic connectivity in learning-related brain regions

BDNF fold-change in the rodent hippocampus

illustrative trace summarising the rodent data described above -- upregulation appears within hours, peaks during sustained dosing, and gradually returns toward baseline after washout. measurement region hippocampal BDNF mRNA

BDNF mRNA fold-change vs untreated controls
rodent BDNF mRNA fold-change over selank treatment days baseline 1.0x 0 0.5x 1.0x 1.5x 2.0x 2.5x day 0 1 3 7 14 21 treatment day BDNF mRNA fold-change day 0 -- 1.0x baseline 1.0x day 1 -- 1.4x baseline (within hours of dosing) 1.4x day 3 -- 1.8x baseline 1.8x day 7 -- ~2.0x peak during dosing 2.05x day 14 -- 1.85x sustained 1.85x day 21 -- 1.35x post-washout 1.35x

illustrative trace summarising the rodent literature described in this unit (Kozlovskii / Filatova line of work on hippocampal BDNF mRNA after intranasal selank). exact magnitudes vary by dose, region, and assay -- this is a teaching schematic, not a single published curve.

interactive explorer

explore the key concepts for this unit.

neurotrophic signaling cascade

key terms

definitions you will encounter throughout this unit.

B BDNF growth factor
brain-derived neurotrophic factor -- a protein that supports the survival of existing neurons and encourages the growth of new neurons and synapses. often called "fertilizer for the brain." low BDNF levels are associated with depression, anxiety, and cognitive decline. exercise, sleep, and certain compounds (including selank in animal models) increase BDNF.
N NGF growth factor
nerve growth factor -- a protein essential for the maintenance and survival of certain types of neurons, particularly in the peripheral nervous system and basal forebrain. NGF supports cholinergic neurons (nerve cells that use acetylcholine), which are critical for memory and attention.
N neuroplasticity mechanism
the brain's ability to reorganize itself by forming new neural connections throughout life. this includes strengthening frequently used pathways (long-term potentiation), weakening unused ones (synaptic pruning), and growing new synapses (synaptogenesis). neuroplasticity is the biological basis of learning and memory.
T TrkB receptor receptor
tropomyosin receptor kinase B -- the primary receptor for BDNF. when BDNF binds TrkB, it triggers intracellular signaling cascades (PI3K/Akt, MAPK/ERK) that promote neuron survival, synaptic plasticity, and gene expression changes. TrkB activation is considered the main mechanism through which BDNF exerts its neuroprotective effects.
H hippocampus anatomy
a seahorse-shaped brain structure in the medial temporal lobe critical for forming new memories, spatial navigation, and emotional regulation. the hippocampus is one of the few brain regions where adult neurogenesis (new neuron formation) occurs. it is also highly sensitive to stress hormones, which can shrink it over time.
N nootropic drug class
a substance that enhances cognitive function -- memory, focus, creativity, or motivation -- without significant side effects. the term was coined in 1972 by Corneliu Giurgea. selank is sometimes classified as a nootropic because of its reported cognitive enhancement effects, which may be mediated through BDNF and NGF upregulation.

what BDNF actually does in your brain -- the simple version

a plain-English walkthrough of how a single protein shapes learning, memory, and mood.

BDNF (brain-derived neurotrophic factor) works like fertilizer for your neurons (brain cells). just as fertilizer helps plants grow stronger roots and branches, BDNF helps neurons grow new connections called synapses (the junctions where one neuron communicates with another). when BDNF levels are high, your brain forms new pathways more easily -- this is the biological basis of learning and memory. when BDNF levels drop (from chronic stress, poor sleep, or aging), those connections weaken and cognitive performance declines. selank, in animal studies, increases BDNF production in the hippocampus (the brain region responsible for forming new memories), which may explain the nootropic (cognitive enhancement) effects reported alongside its anxiety-reducing properties.

A advanced: TrkB signaling cascade term
BDNF exerts its effects by binding to the TrkB receptor (tropomyosin receptor kinase B) on the surface of neurons. this binding triggers two major intracellular signaling pathways. the first is the PI3K/Akt pathway (phosphoinositide 3-kinase / protein kinase B), which promotes neuron survival by blocking apoptosis (programmed cell death). the second is the MAPK/ERK pathway (mitogen-activated protein kinase / extracellular signal-regulated kinase), which drives synaptic plasticity -- the strengthening or weakening of connections based on activity. together, these cascades explain how a single protein can simultaneously protect existing neurons and help new learning occur.
advanced: gene expression studies
a 2012 study by Kozlovskii and Danchev examined selank's effect on gene expression in the rat hippocampus and found significant changes in 84 genes related to neurotrophic signaling. these included upregulation of BDNF and NGF mRNA (the instructions cells use to build these proteins), as well as changes in genes controlling synaptic vesicle cycling (how neurons package and release their chemical signals). the breadth of gene expression changes -- spanning inflammation, neuroprotection, and synaptic function -- suggests selank acts as a broad regulatory signal rather than a single-target drug. however, gene expression changes in rodent tissue do not automatically translate to the same changes in human brains.
advanced: hippocampal neurogenesis
the hippocampus is one of the few brain regions where new neurons can be born in adults -- a process called adult neurogenesis. this happens in the dentate gyrus (a sub-region of the hippocampus), where neural stem cells divide and mature into functional neurons over several weeks. BDNF is a critical driver of this process: it promotes stem cell survival, guides new neurons to integrate into existing circuits, and strengthens their synaptic connections. if selank reliably increases hippocampal BDNF (as rodent data suggests), it could theoretically support neurogenesis. but confirming this in humans would require neuroimaging studies that have not been conducted.

where this has been studied

evidence from published research -- primarily rodent and in-vitro models with no human neurotrophic data.

BDNF upregulation
Kozlovskii and colleagues showed that selank increased BDNF mRNA expression in the rat hippocampus after intranasal administration. the effect was dose-dependent and appeared within hours of treatment, suggesting rapid transcriptional activation rather than slow structural changes.
gene expression profiling
microarray analysis (a technology that measures thousands of genes simultaneously) revealed selank altered expression of 84 genes in the hippocampus. these genes clustered in functional groups related to neurotrophic signaling, inflammation, and synaptic plasticity -- suggesting selank acts as a broad neuromodulator rather than a single-pathway drug.
behavioral tests
in the Morris water maze (a test where rodents learn to find a hidden platform in a pool), selank-treated rats found the platform faster and remembered its location better after delays. these improvements correlated with hippocampal BDNF levels, supporting a causal link between neurotrophic effects and cognitive performance in animals.
NGF / TrkA pathway
alongside BDNF, selank also increased NGF (nerve growth factor) expression. NGF primarily supports cholinergic neurons (nerve cells that use acetylcholine, a neurotransmitter critical for attention and memory) via the TrkA receptor. this dual neurotrophic effect -- BDNF through TrkB plus NGF through TrkA -- is unusual for a single peptide and distinguishes selank from most nootropic compounds.

selank vs other BDNF boosters

how selank compares to other interventions known to increase BDNF.

selank

  • increases BDNF + NGF simultaneously in rodent hippocampus
  • intranasal delivery, rapid onset
  • also reduces anxiety (dual benefit profile)
  • alters expression of 84+ genes beyond just neurotrophins
  • evidence limited to animal models; no human BDNF measurement data

exercise

  • most robust BDNF-boosting intervention in human studies
  • aerobic exercise increases serum BDNF acutely and chronically
  • also improves cardiovascular health, mood, and sleep
  • effect size depends on intensity and duration
  • backed by hundreds of human trials across populations

lion's mane / semax

  • lion's mane (Hericium erinaceus) stimulates NGF via hericenones and erinacines
  • semax (ACTH analog with Pro-Gly-Pro tail) increases BDNF in rodent models
  • lion's mane has small human cognitive trials; semax has Russian clinical data
  • neither has large-scale Western clinical validation for BDNF effects
  • both available as supplements/peptides with varying quality control
evidence ceiling: BDNF and gene expression data come from rodent studies. no human neuroimaging or neurotrophic-marker study of selank has been published. extrapolating rodent neuroplasticity data to human cognitive enhancement requires caution.